Dormancy could further be promoted in experimental breast cancer models via the inhibition of lysophosphatidic acid receptor 1 (LPA1), which induces a p38high/ERKlow state (Marshall et al., 2012). This evidence concerns the gene LPAR1 and breast cancer.